Sung Min Won , Na Young Lee , Ki , Haripriya Gupta , Satya Priya Sharma , Kyung Hwan Kim , Byoung Kook Kim , Hyun Chae Joung , Jin Ju Jeong , Raja Ganesan , Sang Hak Han , Sang Jun Yoon , Dong Joon Kim , Ki Tae Suk
J. Microbiol. 2023;61(2):245-257. Published online February 6, 2023
The progression and exacerbation of liver fibrosis are closely related to the gut microbiome. It is hypothesized that some
probiotics may slow the progression of liver fibrosis. In human stool analysis [healthy group (n = 44) and cirrhosis group
(n = 18)], difference in Lactobacillus genus between healthy group and cirrhosis group was observed. Based on human
data, preventive and therapeutic effect of probiotics Lactobacillus lactis and L. rhamnosus was evaluated by using four
mice fibrosis models. L. lactis and L. rhamnosus were supplied to 3,5-diethoxycarbonyl-1,4-dihydrocollidine or carbon
tetrachloride-induced liver fibrosis C57BL/6 mouse model. Serum biochemical measurements, tissue staining, and mRNA
expression in the liver were evaluated. The microbiome was analyzed in mouse cecal contents. In the mouse model, the
effects of Lactobacillus in preventing and treating liver fibrosis were different for each microbe species. In case of L. lactis,
all models showed preventive and therapeutic effects against liver fibrosis. In microbiome analysis in mouse models administered
Lactobacillus, migration and changes in the ratio and composition of the gut microbial community were confirmed.
L. lactis and L. rhamnosus showed preventive and therapeutic effects on the progression of liver fibrosis, suggesting that
Lactobacillus intake may be a useful strategy for prevention and treatment.
Citations
Citations to this article as recorded by
Enhancing the application of probiotics in probiotic food products from the perspective of improving stress resistance by regulating cell physiological function: A review Dingkang Wang, Ruijie Xu, Sha Liu, Xiaomin Sun, Tianxiao Zhang, Lin Shi, Youfa Wang Food Research International.2025; 199: 115369. CrossRef
Lactobacillus gasseri BNR17 and Limosilactobacillus fermentum ABF21069 Ameliorate High Sucrose-Induced Obesity and Fatty Liver via Exopolysaccharide Production and β-oxidation Yu Mi Jo, Yoon Ji Son, Seul-Ah Kim, Gyu Min Lee, Chang Won Ahn, Han-Oh Park, Ji-Hyun Yun Journal of Microbiology.2024; 62(10): 907. CrossRef
Probiotics modulation of the endotoxemic effect on the gut and liver of the lipopolysaccharide challenged mice Gyan Babu, Banalata Mohanty Drug and Chemical Toxicology.2024; : 1. CrossRef
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023) Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan Frontiers in Microbiology.2024;[Epub] CrossRef
Gut microbes combined with metabolomics reveal the protective effects of Qijia Rougan decoction against CCl4-induced hepatic fibrosis Xue Li, Xinyi Xu, Sian Tao, Yue Su, Li Wen, Dong Wang, Jibin Liu, Quansheng Feng Frontiers in Pharmacology.2024;[Epub] CrossRef
Assessment of probiotic properties of lactic acid bacteria isolated from an artisanal Colombian cheese Samantha Roldán-Pérez, Sara Lucía Gómez Rodríguez, José Uriel Sepúlveda-Valencia, Orlando Simón Ruiz Villadiego, María Elena Márquez Fernández, Olga I. Montoya Campuzano, Mónica María Durango-Zuleta Heliyon.2023; 9(11): e21558. CrossRef
Agrocybe aegerita Polysaccharide Combined with Bifidobacterium lactis Bb-12 Attenuates Aging-Related Oxidative Stress and Restores Gut Microbiota Xiaoyan Liu, Yanyu Feng, Hongmin Zhen, Lina Zhao, Hongqiang Wu, Bin Liu, Guangsen Fan, Aijun Tong Foods.2023; 12(24): 4381. CrossRef
Probiotics and liver fibrosis: An evidence-based review of the latest research Lin Cheng, Jianyou Shi, Haoyuan Peng, Rongsheng Tong, Yonghe Hu, Dongke Yu Journal of Functional Foods.2023; 109: 105773. CrossRef